Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
Journal article published in 2017 by
Bianca Hemmingsen,
David P. Sonne 
,
Maria-Inti Metzendorf,
Bernd Richter
,
Maria-Inti Metzendorf,
Bernd Richter
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 